Sustainability & Climate

A $170M deal to boost infant formula supply has soured for Perrigo, leading to a 25% stock crash, a strategic review, and securities fraud lawsuits.

A routine UK disclosure by an investment giant has pulled back the curtain on a major transatlantic auto merger and the silent influence of institutional capital.

A $2.4B tech acquisition seems distant from healthcare, but Qualcomm's move to buy Alphawave is building the essential AI infrastructure for medicine's future.

An Atlanta clinic's top award highlights a market shift toward minimally invasive fibroid treatment and a crucial fight for health equity in women's care.

With a new M&A-savvy CRO and Blackstone's backing, Enverus is poised for aggressive growth, aiming to dominate the AI-driven future of energy intelligence.

One company's move to standardize a traditional remedy highlights a key strategy for winning trust and market share in the booming wellness industry.

A routine dividend from Imperial Petroleum reveals a powerful strategy: a debt-free balance sheet and cash-funded growth in a volatile shipping market.

A new partnership brings Febreze's brand power to the overlooked cabin air filter, aiming to transform a maintenance task into a premium consumer choice.

An Australian biotech's novel gel delivery system aims to conquer China's wellness market. But can superior tech alone build the trust needed to succeed?

Stunning trial data reveals an immunotherapy combo that slashes myeloma progression by 83%, offering not just longer life but a better quality of life.

BDO USA's launch of a new government unit isn't just a merger. It's a strategic play to dominate the high-stakes world of public sector recovery.

Domestic manufacturing, massive power demands from AI and EVs, and a skilled labor shortage are converging to define a pivotal year for American industry.

A new study reveals a simple dietary change—swapping carb snacks for tree nuts—can curb cravings for junk food and improve health in young adults.

Angeion Group's appointment of a legal marketing veteran isn't just a new hire; it's a calculated move to challenge rivals and dominate its niche.

Eli Lilly's takeover of Adverum signals a major push into ocular gene therapy. Can a one-time injection for vision loss disrupt a multi-billion dollar market?

Beyond a simple product launch, a strategic acquisition is fueling innovations in drug delivery that could transform patient care for millions worldwide.

A new narcolepsy drug could finally offer patients what they've been missing: a single nightly dose with low sodium, transforming lives and the market.

PTC launches its Arena AI Engine to automate compliance and document review, offering a strategic advantage for complex defense and aerospace supply chains.

A new patent for reactivated carbon technology offers a circular solution to destroy "forever chemicals," promising a reliable path for U.S. water safety.

The waterpark giant is investing millions to trade slides for serenity. We analyze Kalahari's strategic leap into the booming luxury experience market.